Alterations in renal function in psoriasis patients treated with cyclosporin, 5 mg/kg/day

David Joel Margolis, Cynthia Guzzo, Joan Johnson, Gerald S. Lazarus

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Cyclosporine has been used to treat a variety of cutaneous and immune-mediated diseases. Nephrotoxicity is the most common major adverse side effect. Objective: The study was designed to investigate the frequency of alterations in serum creatinine in patients with psoriasis receiving 5 mg/kg/day of cyclosporine. Methods: Sixteen patients with severe refractory psoriasis received cyclosporine, 5 mg/kg/ day, for 12 weeks. Serum creatinine was evaluated with respect to each patient's baseline. Results: Serum creatinine levels remained in the normal range, but 10 of 16 patients had a 30% elevation and 5 of 16 patients had a 50% elevation of serum creatinine compared with the patient's baseline value. Conclusion: These results indicate that a significant elevation in serum creatinine occurs in many patients who receive cyclosporine for psoriasis.

Original languageEnglish (US)
Pages (from-to)195-197
Number of pages3
JournalJournal of the American Academy of Dermatology
Volume26
Issue number2
DOIs
StatePublished - Jan 1 1992
Externally publishedYes

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Alterations in renal function in psoriasis patients treated with cyclosporin, 5 mg/kg/day'. Together they form a unique fingerprint.

Cite this